Literature DB >> 26858406

Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction.

Brandon L Crowe1, Ross C Larue2, Chunhua Yuan3, Sonja Hess4, Mamuka Kvaratskhelia2, Mark P Foster5.   

Abstract

The bromodomain and extraterminal domain (BET) protein family are promising therapeutic targets for a range of diseases linked to transcriptional activation, cancer, viral latency, and viral integration. Tandem bromodomains selectively tether BET proteins to chromatin by engaging cognate acetylated histone marks, and the extraterminal (ET) domain is the focal point for recruiting a range of cellular and viral proteins. BET proteins guide γ-retroviral integration to transcription start sites and enhancers through bimodal interaction with chromatin and the γ-retroviral integrase (IN). We report the NMR-derived solution structure of the Brd4 ET domain bound to a conserved peptide sequence from the C terminus of murine leukemia virus (MLV) IN. The complex reveals a protein-protein interaction governed by the binding-coupled folding of disordered regions in both interacting partners to form a well-structured intermolecular three-stranded β sheet. In addition, we show that a peptide comprising the ET binding motif (EBM) of MLV IN can disrupt the cognate interaction of Brd4 with NSD3, and that substitutions of Brd4 ET residues essential for binding MLV IN also impair interaction of Brd4 with a number of cellular partners involved in transcriptional regulation and chromatin remodeling. This suggests that γ-retroviruses have evolved the EBM to mimic a cognate interaction motif to achieve effective integration in host chromatin. Collectively, our findings identify key structural features of the ET domain of Brd4 that allow for interactions with both cellular and viral proteins.

Entities:  

Keywords:  BET family transcription factor; ET binding motif (EBM); NMR; protein–protein interaction; retroviral integration

Mesh:

Substances:

Year:  2016        PMID: 26858406      PMCID: PMC4776507          DOI: 10.1073/pnas.1516813113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Using NMRView to visualize and analyze the NMR spectra of macromolecules.

Authors:  Bruce A Johnson
Journal:  Methods Mol Biol       Date:  2004

Review 2.  Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

5.  Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p.

Authors:  W Xie; X Gai; Y Zhu; D C Zappulla; R Sternglanz; D F Voytas
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding.

Authors:  Katrien Busschots; Jo Vercammen; Stéphane Emiliani; Richard Benarous; Yves Engelborghs; Frauke Christ; Zeger Debyser
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

7.  The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.

Authors:  Jan De Rijck; Christine de Kogel; Jonas Demeulemeester; Sofie Vets; Sara El Ashkar; Nirav Malani; Frederic D Bushman; Bart Landuyt; Steven J Husson; Katrien Busschots; Rik Gijsbers; Zeger Debyser
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

8.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

9.  MLV integration site selection is driven by strong enhancers and active promoters.

Authors:  Matthew C LaFave; Gaurav K Varshney; Derek E Gildea; Tyra G Wolfsberg; Andreas D Baxevanis; Shawn M Burgess
Journal:  Nucleic Acids Res       Date:  2014-01-23       Impact factor: 16.971

10.  Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.

Authors:  Ross C Larue; Matthew R Plumb; Brandon L Crowe; Nikoloz Shkriabai; Amit Sharma; Julia DiFiore; Nirav Malani; Sriram S Aiyer; Monica J Roth; Frederic D Bushman; Mark P Foster; Mamuka Kvaratskhelia
Journal:  Nucleic Acids Res       Date:  2014-02-11       Impact factor: 16.971

View more
  31 in total

Review 1.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

2.  The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes.

Authors:  Ryan J Conrad; Parinaz Fozouni; Sean Thomas; Hendrik Sy; Qiang Zhang; Ming-Ming Zhou; Melanie Ott
Journal:  Mol Cell       Date:  2017-08-24       Impact factor: 17.970

Review 3.  Targeting Cancer Cells with BET Bromodomain Inhibitors.

Authors:  Yali Xu; Christopher R Vakoc
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

4.  The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.

Authors:  Dorothy C C Wai; Taylor N Szyszka; Amy E Campbell; Cherry Kwong; Lorna E Wilkinson-White; Ana P G Silva; Jason K K Low; Ann H Kwan; Roland Gamsjaeger; James D Chalmers; Wayne M Patrick; Bin Lu; Christopher R Vakoc; Gerd A Blobel; Joel P Mackay
Journal:  J Biol Chem       Date:  2018-03-22       Impact factor: 5.157

5.  Post-mitotic BET-induced reshaping of integrase quaternary structure supports wild-type MLV integration.

Authors:  Doortje Borrenberghs; Irena Zurnic; Flore De Wit; Aline Acke; Lieve Dirix; Anna Cereseto; Zeger Debyser; Jelle Hendrix
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

Review 6.  What Integration Sites Tell Us about HIV Persistence.

Authors:  Stephen H Hughes; John M Coffin
Journal:  Cell Host Microbe       Date:  2016-05-11       Impact factor: 21.023

7.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

8.  Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.

Authors:  Aktan Alpsoy; Emily C Dykhuizen
Journal:  J Biol Chem       Date:  2018-01-26       Impact factor: 5.157

Review 9.  Bromodomain 4: a cellular Swiss army knife.

Authors:  Ballachanda N Devaiah; Anne Gegonne; Dinah S Singer
Journal:  J Leukoc Biol       Date:  2016-07-22       Impact factor: 4.962

10.  Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4.

Authors:  Qiang Zhang; Lei Zeng; Chen Shen; Ying Ju; Tsuyoshi Konuma; Chengcheng Zhao; Christopher R Vakoc; Ming-Ming Zhou
Journal:  Structure       Date:  2016-06-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.